Line Arnould
Impact in
- Virology top 5%
- HIV Research and Treatment
- Infectious Diseases top 5%
- HIV/AIDS Research and Interventions
- HIV/AIDS drug development and treatment
Papers in
- Virology 5
- HIV Research and Treatment 5
-
- HIV/AIDS Research and Interventions 10
- HIV/AIDS drug development and treatment 6
- Co-authors
- Rony ZachariahAnthony HarriesMoses MassaquoiMargaret FitzgeraldSimon D MakombeMarcel ManziBeatrice MwagombaD. O’Brien
In The Last Decade
Line Arnould
15 papers receiving 460 citations
Peers
Comparison fields: 5 of 45
- Virology 203
- Infectious Diseases 397
- Emergency Medicine 131
- Epidemiology 168
- Safety Research 35
Countries citing papers authored by Line Arnould
This map shows the geographic impact of Line Arnould's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Line Arnould with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Line Arnould more than expected).
Fields of papers citing papers by Line Arnould
This network shows the impact of papers produced by Line Arnould. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Line Arnould. The network helps show where Line Arnould may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Line Arnould, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2012 | 4 | |
| 2 | 2011 | 16 | |
| 3 | 2011 | 37 | |
| 4 | 2010 | 15 | |
| 5 | 2009 | 20 | |
| 6 | 2009 | 32 | |
| 7 | 2009 | 42 | |
| 8 | 2008 | 15 | |
| 9 | 2007 | 32 | |
| 10 | 2006 | 229 | |
| 11 | Telemedicine for HIV/AIDS Care in Low Resource Settings. | 2005 | 8 |
| 12 | [Lympho-epithelial lesions induced by plasma cells in a pulmonary MALT lymphoma]. | 1994 | 3 |
| 13 | 1991 | 20 | |
| 14 | [Invasive adenocarcinoma with epidermoid carcinoma on the site of bladder exstrophy. Histochemical and immunocytochemical study]. | 1991 | 3 |
| 15 | [A case of liver angiosarcoma arising in a pre-existing cavernous hemangioma]. | 1990 | 6 |
About Line Arnould
Line Arnould is a scholar working on Virology, Infectious Diseases, Urology, Pediatrics, Perinatology and Child Health and Hepatology, having authored 15 papers that have together received 482 indexed citations. Recurring topics across this work include HIV/AIDS Research and Interventions (10 papers), HIV/AIDS drug development and treatment (6 papers), HIV Research and Treatment (5 papers), Global Maternal and Child Health (3 papers), Vascular Tumors and Angiosarcomas (2 papers), Pneumocystis jirovecii pneumonia detection and treatment (2 papers), HIV/AIDS Impact and Responses (2 papers) and Lymphoma Diagnosis and Treatment (2 papers). The work is most often cited by research in Virology (203 citations), Infectious Diseases (397 citations), Emergency Medicine (131 citations), Epidemiology (168 citations) and Safety Research (35 citations). Line Arnould has collaborated with scholars based in France, Belgium and Uganda. Frequent co-authors include Rony Zachariah, Anthony Harries, Moses Massaquoi, Margaret Fitzgerald, Simon D Makombe, Marcel Manzi, Beatrice Mwagomba, D. O’Brien, Lutgarde Lynen and Tony Petrella. Their work appears in journals such as Transactions of the Royal Society of Tropical Medicine and Hygiene, JAIDS Journal of Acquired Immune Deficiency Syndromes, Tropical Medicine & International Health, Clinical Infectious Diseases and International Health.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.